Marketcap : 176 mio$
Outlook:
Licensing - secure significant new deal
Evamist™ - VIVUS files Evamist marketing application with FDA
(achieved September 2006)
Testosterone MDTS® - VIVUS starts Phase 3 trials (H1 2007)
Contraceptive sprays - start proof of concept trials of combinations
Testosterone MD-Lotion® - complete Phase 2 trials (H1 2007)
New products - one successful proof of concept trial
Fentanyl UDTS™ - open IND with FDA for Phase 2
Cash - maintain above $10 million at all times
top biotech : great opportunity
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.69M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 60019 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.9¢ | 225945 | 1 |
View Market Depth
| Last trade - 16.12pm 18/09/2024 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable